Shopping Cart
- Remove All
- Your shopping cart is currently empty
Antitumor agent-164 (compound 60c), a next-generation derivative of VERU-111, serves as a colchicine binding site inhibitor (CBSI). It is effective against taxane-sensitive triple-negative breast cancer (TNBC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Antitumor agent-164 (compound 60c), a next-generation derivative of VERU-111, serves as a colchicine binding site inhibitor (CBSI). It is effective against taxane-sensitive triple-negative breast cancer (TNBC). |
Molecular Weight | 397.4 |
Formula | C22H20FNO5 |
Cas No. | 2757188-21-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.